BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 26965729)

  • 41. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
    Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
    Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Additive value of magnetic resonance coronary angiography in a comprehensive cardiac magnetic resonance stress-rest protocol for detection of functionally significant coronary artery disease: a pilot study.
    Bettencourt N; Ferreira N; Chiribiri A; Schuster A; Sampaio F; Santos L; Melica B; Rodrigues A; Braga P; Teixeira M; Leite-Moreira A; Silva-Cardoso J; Portugal P; Gama V; Nagel E
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):730-8. PubMed ID: 23833284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging.
    Cullen JH; Horsfield MA; Reek CR; Cherryman GR; Barnett DB; Samani NJ
    J Am Coll Cardiol; 1999 Apr; 33(5):1386-94. PubMed ID: 10193743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.
    Mygind ND; Michelsen MM; Pena A; Qayyum AA; Frestad D; Christensen TE; Ghotbi AA; Dose N; Faber R; Vejlstrup N; Hasbak P; Kjaer A; Prescott E; Kastrup J;
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):76. PubMed ID: 27809867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Qualitative and semi-quantitative evaluation of myocardium perfusion with 3 T stress cardiac MRI.
    Yun CH; Tsai JP; Tsai CT; Mok GS; Sun JY; Hung CL; Wu TH; Huang WT; Yang FS; Lee JJ; Cury RC; Fares A; Nshisso LD; Bezerra HG
    BMC Cardiovasc Disord; 2015 Dec; 15():164. PubMed ID: 26642757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
    Bhave NM; Freed BH; Yodwut C; Kolanczyk D; Dill K; Lang RM; Mor-Avi V; Patel AR
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):89. PubMed ID: 23272658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Semi-quantitative myocardial perfusion measured by computed tomography in patients with refractory angina: a head-to-head comparison with quantitative rubidium-82 positron emission tomography as reference.
    Qayyum AA; Kühl JT; Kjaer A; Hasbak P; Kofoed KF; Kastrup J
    Clin Physiol Funct Imaging; 2017 Sep; 37(5):481-488. PubMed ID: 26625937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrated cardiac magnetic resonance imaging with coronary magnetic resonance angiography, stress-perfusion, and delayed-enhancement imaging for the detection of occult coronary artery disease in asymptomatic individuals.
    Song KD; Kim SM; Choe YH; Jung W; Lee SC; Chang SA; Choi YH; Sung J
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():77-89. PubMed ID: 25916321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myocardial perfusion is impaired in asymptomatic renal and liver transplant recipients: a cardiovascular magnetic resonance study.
    Parnham S; Gleadle JM; Leong D; Grover S; Bradbrook C; Woodman RJ; De Pasquale CG; Selvanayagam JB
    J Cardiovasc Magn Reson; 2015 Jul; 17():56. PubMed ID: 26160365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance.
    Zhou W; Lee JCY; Leung ST; Lai A; Lee TF; Chiang JB; Cheng YW; Chan HL; Yiu KH; Goh VK; Pennell DJ; Ng MY
    JACC Cardiovasc Imaging; 2021 Mar; 14(3):602-611. PubMed ID: 33248966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography.
    Osto E; Tona F; Angelini A; Montisci R; Ruscazio M; Vinci A; Tarantini G; Ramondo A; Gambino A; Thiene G; Caforio AL; Gerosa G; Iliceto S
    J Heart Lung Transplant; 2009 May; 28(5):453-60. PubMed ID: 19416773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy.
    van Heeswijk RB; Bastiaansen JAM; Iglesias JF; Degrauwe S; Rotman S; Barras JL; Regamey J; Lauriers N; Tozzi P; Yerly J; Ginami G; Stuber M; Hullin R
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):533-542. PubMed ID: 31724114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The STRATEGY Study (Stress Cardiac Magnetic Resonance Versus Computed Tomography Coronary Angiography for the Management of Symptomatic Revascularized Patients): Resources and Outcomes Impact.
    Pontone G; Andreini D; Guaricci AI; Rota C; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Solbiati A; Segurini C; Conte E; Gripari P; Annoni A; Formenti A; Petulla' M; Lombardi F; Muscogiuri G; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27894070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microvasculopathy observed in early or late endomyocardial biopsies is not related to angiographically confirmed transplanted heart coronary vasculopathy.
    Zakliczyński M; Konecka-Mrówka D; Lekston A; Nozyński J; Pyka L; Trybunia D; Swierad M; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3209-13. PubMed ID: 19857712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of cardiovascular risk factors on myocardial perfusion and fibrosis in asymptomatic individuals: cardiac magnetic resonance study.
    Cha MJ; Kim SM; Kim HS; Kim Y; Choe YH
    Acta Radiol; 2018 Nov; 59(11):1300-1308. PubMed ID: 29433344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population.
    Buckert D; Dewes P; Walcher T; Rottbauer W; Bernhardt P
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):56-63. PubMed ID: 23328562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial perfusion cardiac magnetic resonance for the diagnosis of coronary artery disease: do we need rest images?
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Nakyen S; Thanapiboonpol P; Yindeengam A; Udompunturak S
    Int J Cardiovasc Imaging; 2009 Apr; 25 Suppl 1():139-48. PubMed ID: 19132546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location.
    Manka R; Paetsch I; Kozerke S; Moccetti M; Hoffmann R; Schroeder J; Reith S; Schnackenburg B; Gaemperli O; Wissmann L; Wyss CA; Kaufmann PA; Corti R; Boesiger P; Marx N; Lüscher TF; Jahnke C
    Eur Heart J; 2012 Aug; 33(16):2016-24. PubMed ID: 22677136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease.
    Stuijfzand WJ; Uusitalo V; Kero T; Danad I; Rijnierse MT; Saraste A; Raijmakers PG; Lammertsma AA; Harms HJ; Heymans MW; Huisman MC; Marques KM; Kajander SA; Pietilä M; Sörensen J; van Royen N; Knuuti J; Knaapen P
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
    Kazmirczak F; Nijjar PS; Zhang L; Hughes A; Chen KA; Okasha O; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):9. PubMed ID: 30674318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.